Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma

被引:17
作者
Devor, Eric J. [1 ]
De Mik, Jillian N. [1 ]
Ramachandran, Shyam [2 ]
Goodheart, Michael J. [1 ,3 ]
Leslie, Kimberly K. [1 ,3 ]
机构
[1] Univ Iowa, Carver Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA
[2] Univ Iowa, Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA
[3] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
关键词
microRNA; uterine carcinosarcoma; chromosome; 14q32; GENE-EXPRESSION DATA; MESENCHYMAL TRANSITION; UTERUS; CARCINOMAS; TUMORS; MICRORNAS; RNAS;
D O I
10.3892/etm.2012.458
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Uterine carcinosarcoma (UCS) is a rare but very aggressive cancer of the female reproductive tract with an extremely poor prognosis. With the goal of understanding the role of microRNA (miRNA) dysregulation in these tumors, we profiled the expression of 667 human miRNAs in a panel of eight UCS patients and five benign control primary tissue samples. These expression profiles revealed two important characteristics of UCS. First, compared with the two most common uterine cancers, endometrial endometrioid adenocarcinoma and endometrial serous adenocarcinoma, UCS samples display a virtually unique pattern of miRNA dysregulation with an overlap of only 5% among the three tumor types. In addition, nearly one-third of the miRNAs significantly dysregulated in UCS tissues compared with benign endometrium (32 of 114) lie in a single small (250-kb) imprinted region of chromosome 14q32. These data suggest that the presence of such a global, region-specific disruption substantially contributes to the unique histology and poor outcome of this type of cancer.
引用
收藏
页码:677 / 682
页数:6
相关论文
共 32 条
[1]  
Abeln ECA, 1997, J PATHOL, V183, P424
[2]   Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma [J].
Angeles Castilla, Maria ;
Moreno-Bueno, Gema ;
Romero-Perez, Laura ;
Van De Vijver, Koen ;
Biscuola, Michele ;
Angeles Lopez-Garcia, Maria ;
Prat, Jaime ;
Matias-Guiu, Xavier ;
Cano, Amparo ;
Oliva, Esther ;
Palacios, Jose .
JOURNAL OF PATHOLOGY, 2011, 223 (01) :72-80
[3]   MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents [J].
Cochrane, Dawn R. ;
Spoelstra, Nicole S. ;
Howe, Erin N. ;
Nordeen, Steven K. ;
Richer, Jennifer K. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (05) :1055-1066
[4]   Uterine sarcomas: A review [J].
D'Angelo, Emanuela ;
Prat, Jaime .
GYNECOLOGIC ONCOLOGY, 2010, 116 (01) :131-139
[5]   microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs [J].
Devor, Eric J. ;
Hovey, Adriann M. ;
Goodheart, Michael J. ;
Ramachandran, Shyam ;
Leslie, Kimberly K. .
ONCOLOGY REPORTS, 2011, 26 (04) :995-1002
[6]   Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia [J].
Dixon-McIver, Amanda ;
East, Phil ;
Mein, Charles A. ;
Cazier, Jean-Baptiste ;
Molloy, Gael ;
Chaplin, Tracy ;
Lister, T. Andrew ;
Young, Bryan D. ;
Debernardi, Silvana .
PLOS ONE, 2008, 3 (05)
[7]  
EVANS HL, 1988, CANCER-AM CANCER SOC, V62, P2239, DOI 10.1002/1097-0142(19881115)62:10<2239::AID-CNCR2820621028>3.0.CO
[8]  
2-Y
[9]  
Fujii H, 2000, CANCER RES, V60, P114
[10]   Methylation analysis of the intergenic differentially methylated region of DLK1-GTL2 in human [J].
Geuns, Elke ;
De Temmerman, Nele ;
Hilven, Pierre ;
Van Steirteghem, Andre ;
Liebaers, Inge ;
De Rycke, Martine .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (03) :352-361